abstract: Gestational choriocarcinomas are malignant tumors of trophoblastic cells that affect 5-25% of women with sporadic hydatidiform moles (HMs) depending on countries and studies. Nucleotide binding and oligomerization domain-like receptor protein 7 (NLRP7) is a major gene responsible for recurrent HMs and recently mutations in this gene have also been shown in 13% of women with sporadic, nonrecurrent moles. To investigate the role of NLRP7 in the genetic susceptibility for the malignant degeneration of moles, we sequenced its 11 exons in 43 Senegalese patients with post-molar choriocarcinomas. We report the presence of three novel NLRP7 variants that were found only in patients but not in 100 controls from the Senegalese general population, 100 controls from the Tunisian general population, and 100 controls from the Canadian population. In addition, this analysis revealed significant differences in the frequencies of four non-synonymous NLRP7 variants between European and Senegalese controls with the biggest difference being for variant G487E present at a minor allele frequency of 3.5% in Europeans, 18.1% in Tunisians and 45.6% in Senegalese. Comparing human NLRP7 and its paralog, NLRP2, with their mammalian counterparts revealed that allele E at position 487 is most likely the ancestral allele that was acquired in Africa but driven to low frequencies in Europeans and Asians due to migration, population bottlenecks and selective pressures. This study is the first attempt to investigate the role of NLRP7 in choriocarcinomas and highlights the higher frequencies of NLRP7 variants in the general Senegalese and Tunisian populations both known to have higher frequencies of moles and choriocarcinomas.
Introduction
Hydatidiform mole (HM) is an aberrant human pregnancy with no embryo and excessive proliferation of trophoblastic cells. The common form of this condition is sporadic, not recurrent and affects 1 in every 250 pregnancies in western countries (all types included) (Seckl et al., 2010) . This frequency is 2-10 times higher in developing and underdeveloped countries (Grimes, 1984; Bracken, 1987; Altieri et al., 2003) . At the histopathological level, HMs are divided into complete HMs (CHMs) and partial HMs. HMs are also tumors of the trophoblast and are usually benign. However, in 5% of CHM cases in western countries, moles degenerate into choriocarcinomas, which are malignant aggressive and highly metastatic tumors that might cause the death of the patients in cases of late presentation or inappropriate management. Again, in developing and underdeveloped countries, up to 30% of CHM degenerate into choriocarcinomas (Cisse et al., 2002; Moodley et al., 2003; Xue et al., 2004) and in these countries, deaths from this condition affect up to 50% of choriocarcinoma cases (Eniola et al., 2001; Cisse et al., 2002; Khabouze et al., 2002; Moodley et al., 2003) . Gestational choriocarcinomas may occur after any type of pregnancies, ectopic pregnancy, blighted ovum, spontaneous abortion, partial or CHM, stillbirth or normal pregnancy, but their risk increases by 1000-2000 times after a molar pregnancy (Buckely, 1996; Altieri et al., 2003) . We note that choriocarcinomas may also have a non-gestational origin resulting from male or female germ cell tumors. However, in this study, we deal only with gestational choriocarcinomas to which we refer hereafter, for simplicity, as choriocarcinomas.
Epidemiological studies have shown the following risk factors for choriocarcinomas, a history of a prior molar pregnancy, late maternal age, large parity (number of pregnancies), previous fetal wastage, oral contraceptive drugs and maternal ethnicity. In studies performed in multiethnic communities from Singapore, Hawaii, and the USA, Asian and African-American patients were found to have higher risks for choriocarcinomas than Caucasians living in the same communities (Buckely, 1996) , which indicate the presence of genetic factors that are more frequent in Asians and African-Americans and that predispose the patients to choriocarcinomas.
NLRP7 (Nucleotide binding and oligomerization domain-like receptor protein 7) is a gene that was originally reported as responsible for recurrent moles and associated reproductive wastage (Murdoch et al., 2006) . Later, mutations in this gene were also found in some women with one mole, associated or not with other forms of reproductive wastage (Messaed et al., 2011; Qian et al., 2011) . Most analyzed molar tissues from patients with NLRP7 mutations have been found to be diploid biparental, but some recently analyzed tissues were found to be diploid androgenetic or triploid dispermic indicating the involvement of NLRP7 in different genotypic types of moles. To date, triploid dispermic and diploid androgenetic moles were all found in patients with one NLRP7 defective allele while diploid biparental moles were found in patients with two defective alleles.
To investigate the role of NLRP7 in the malignant degeneration of moles, we sequenced this gene in a cohort of 43 Senegalese women with post-molar choriocarcinomas. We report the identification of three novel NLRP7 variants in the patients. However, we did not identify any significant association between nonsynonymous variants (NSVs) in NLRP7 and choriocarcinomas. In addition, we show increased frequencies of NSVs in controls from the general population of two African populations known to have higher incidences of moles and choriocarcinomas than Europeans.
Materials and Methods

Patients and control materials
All patients were recruited at the Obstetrics and Gynecology Department of the Aristide Le Dantec Hospital in Dakar (Senegal). The diagnosis of the moles was based on the hydropic degeneration of chorionic villi, the absence of fetal vessels and the presence of important trophoblastic proliferation on most chorionic villi. No slides or tissues from the moles were available to us. All moles were histopathologically diagnosed as CHMs with the exception of one that was diagnosed as partial mole and had a triploid diandric genome. The diagnosis of choriocarcinomas was based on histopathological findings, the absence of chorionic villi and the presence of invasive proliferation of syncytiotrophoblasts and cytotrophoblasts surrounded by necrosis and hemorrhage. In 25% of cases, choriocarcinoma tissues were available to us and their histopathological evaluations confirmed the previous diagnoses. Controls from three different ethnic groups were used in this study, 100 subjects from the Senegalese general population, 100 subjects from the Tunisian general population and 100 subjects from Canadian population of European ancestry. The full reproductive history of all the controls is not known, only the number of children of Europeans and Tunisians were available and the controls included males and females.
Mutation analysis
Mutation analysis was performed on blood DNA from the patients by genomic DNA amplification of the 11 exons of NLRP7 (coding and 5 ′ and 3 ′ untranslated regions) and direct sequencing in the two directions. Sequences were aligned with reference sequence NM_001127255.1 and annotated according to the Human Genome Variation Society guidelines. Nucleotide numbering for mutations and variants uses cDNA numbering with +1 corresponding to the A of the ATG translation initiation codon in the reference sequence. Mutation analysis on control samples was performed under the same conditions used for patients by PCR amplification of one amplicon, covering the region from amino acid 300 to amino acid 515, that was sequenced in one direction. In addition, the following variants, V319I, A481T, G487E, K511R, S675T, R721Q, R795C, A833T and T1028A were individually genotyped in 100 Senegalese controls using the Sequenom w iPLEX w Gold genotyping technology at the McGill University and Genome Quebec Innovation Centre.
Results and Discussion
Among the 43 unrelated Senegalese patients analyzed, we found three novel missense variants in NLRP7, in heterozygous state, that were not seen either in 100 Senegalese controls from the general population nor in another cohort of 100 African controls from the Tunisian general population (Tables I and II ). In addition, none of these variants was seen in 100 Canadian controls of European ancestry from the general population (for additional controls see Supplementary data, Table S1 ). In one Senegalese patient, we found a heterozygous missense variant, R390H, which we previously reported in another patient originating from Guadeloupe and living in Canada who had had one complete mole, one normal pregnancy and a choriocarcinoma after one of her four spontaneous abortions (Messaed et al., 2011) . This variant was also found in one Senegalese control whose reproductive history is not available. Using Polyphen 2 for human variations, a software that predicts possible impact of an amino acid substitution on the structure and function of a protein using structural, evolutionary and comparative considerations, one missense variant, G498R, was predicted to be probably damaging, and two others, S675T and R721Q were predicted to be benign (Supplementary data, Table S1 ). None of the three new variants is reported in the 1000 Genomes database in which data from more than 500 individual genotypes from various populations are available for NLRP7. These three missense variants could (i) be pathogenic, (ii) increase the susceptibility of the patients for moles or choriocarcinomas or (iii) be simply very rare variants that were not seen in our cohorts of controls. Future studies are needed to clarify their status with respect to moles and choriocacinomas. These data are in agreement with a previous study from our group showing NLRP7 mutations in only 13% of patients with one mole and mainly in those who had had other forms of reproductive wastage in addition to their moles (Messaed et al., 2011) , which is not the case of these patients who did not have significant history of reproductive wastage. On the contrary, most of the patients included in this study are multiparous (and had had a large number of children), which is a known risk factor for choriocarcinomas in this population (Cisse et al., 2002) We note that we identified another variant, R795C, present at the same frequency in Senegalese patients and controls, but not in European controls, and that was predicted by Polyphen 2 to be NLRP7 NP, normal pregnancy; HM-CC, hydatidiform mole followed by choriocarcinoma; SA, spontaneous abortion; SB, stillbith. We note that the chronological orders of the NP relative to the other forms of reproductive wastage are not known. However, all the indicated pregnancies occurred before the HM that lead to CC.
possibly damaging. Beside R795C, we did not identify any other novel variant in the Senegalese controls that was not present in the patients.
Comparing the frequencies of NSVs between Senegalese patients and controls did not reveal any statistically significant difference, indicating that the NSVs in NLRP7 do not increase the genetic susceptibility for sporadic moles followed by choriocarcinomas in the analyzed patients (Table II) . Our findings corroborate previous studies implicating environmental factors in the etiology of choriocarcinomas in Senegal (Cisse et al., 2002) . Although we cannot exclude the involvement of other genes, the genetic predisposition for choriocacinomas, in general, does not seem to be strong because choriocarcinomas have never been seen or reported as a recurrent condition in the same patient or as a familial condition in related patients.
Another important observation in this study is the significant differences between the frequencies of four NSVs, V319I, A481T, G487E and K511R between the Senegalese (Sub-Saharan African) and European (Northern) populations with the Tunisian population (Mediterranean) having intermediate frequencies (Table II) (Fig. 1) and are probably very old. In addition, glutamic acid (E) at position 487 that was found at a minor allele frequency of 3.5% in Europeans versus 18.1% in Tunisians, and 45.5% in Senegalese is also present in all primates and lower mammalian species (Fig. 1) . This minor allele, E, is present at low frequencies in Asian populations. Altogether, these data indicate that the rare allele in Europeans, E, is indeed the ancestral allele that was acquired in Africa but lost in Europeans due to migration, population bottlenecks or/and the presence of positive and negative selective pressures. Recently, we found an association between rare NLRP7 NSVs and recurrent reproductive wastage in Europeans (Messaed et al., 2011) . Despite the lack of association between these rare NSVs and choriocarcinomas in Senegalese patients, the higher frequencies of NSVs in African populations known to have higher frequencies of benign moles and choriocarcinomas is interesting and deserves to be re-investigated in the future in patients with recurrent reproductive wastage and larger cohorts of patients and controls.
